InvestorsHub Logo
Followers 245
Posts 33789
Boards Moderated 5
Alias Born 09/29/2005

Re: Never_Post post# 237469

Friday, 11/03/2017 10:37:51 AM

Friday, November 03, 2017 10:37:51 AM

Post# of 290030
There are alternatives to TRTC if one wants to partner up with Big Tobacco.

Companies like http://www.reynoldsamerican.com/Home/default.aspx.?

CLARENCE, N.Y.--(BUSINESS WIRE)--22ndxxxxxxxxx. (NYSE American:xxxx), a plant biotechnology company focused on tobacco harm reduction, announced today that the Company has closed a registered direct common stock offering with institutional investors to receive approximately $54 million in gross proceeds through the sale of 20.57 million shares of common stock at a price of $2.625 per share.

"On October 31, 2017, the Board of Directors of 22xxxxxxxx, Inc. (the “Company”) appointed James E. Swauger, Ph.D., as Senior Vice President of Science and Regulatory Affairs of the Company.

Dr. Swauger, age 56, was previously a leader of the scientific and regulatory functions at Reynolds American Inc. and its affiliates (“Reynolds”) where Dr. Swauger was employed for 23 years from 1993 through 2016 in various positions of significant scientific and regulatory responsibilities with Reynolds, including his service as the Vice President of Regulatory Oversight at Reynolds from 2008 to 2016."

xxxxxx is a plant biotechnology company focused on genetic engineering and modern plant breeding which allows the increase or decrease of the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants. The Company’s primary mission in tobacco is to reduce the harm caused by smoking. The Company’s primary mission in cannabis is to develop proprietary hemp/cannabis strains for important new medicines and agricultural crops. Visit www.xxxxxxxxxxxxxxxxxxxxxxxxxxx